Navigation Links
Cancer therapy more potent when it hits 2 targets
Date:2/24/2012

Simultaneous targeting of two different molecules in cancer is an effective way to shrink tumors, block invasion, and stop metastasis, scientists at the University of California, San Francisco (UCSF) have foundwork that may improve the effectiveness of combination treatments that include drugs like Avastin.

The two-target approach, tested in mice with a type of cancer known as neuroendocrine pancreatic tumors, may have broad application for treating a wide variety of cancers, the UCSF team said. The drugs used in the tests belong to classes of pharmaceuticals that are either on the market or under development in clinical trials.

Clinical trials also are already underway to gauge effectiveness of the approach in humans with prostate cancer, breast cancer, and other tumor types. The UCSF study, described in the journal Cancer Discovery this week, is the first to show how the drug combination works in the laboratory.

The results are promising, said Donald McDonald, MD, PhD, a member of the UCSF Helen Diller Comprehensive Cancer Center and the Cardiovascular Research Institute and professor of anatomy, who led the research.

In the study, treating mice with the dual-target approach turned aggressive tumors with invasive fingers penetrating surrounding tissues and many metastases into tiny balls with few or no metastases.

"It's the combination of approachesthere's a synergy between the two," McDonald said. "You add two and two, and you get 10."

HOW EACH TARGET WORKS

The two targets are both proteins that scientists have known for years are involved in cancer. Both play important roles in malignant tumors.

The first, called c-MET, is involved in two processes associated with the most deadly cancers. A clinical marker of cancer aggressiveness, c-MET drives tumor invasion into surrounding tissues. It is also involved in metastasisthe spread of cancer cells to other parts of th
'/>"/>

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Breast cancer treatment resistance linked to signaling pathway
2. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
3. The dietary supplement genistein can undermine breast cancer treatment
4. Saliva proteins could help detection of oral cancer
5. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
6. Breakthrough optical technology to assess colon cancer risk, accuracy
7. Breast cancer cells recycle to escape death by hormonal therapy
8. Nanodiamond drug device could transform cancer treatment
9. Second lumpectomy for breast cancer reduces survival rates
10. Study looks at psychological impact of gene test for breast cancer
11. SNM releases new fact sheet on breast cancer and molecular imaging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer therapy more potent when it hits 2 targets
(Date:7/20/2015)... -- Acuity Market Intelligence,s latest research "The Global Biometrics ... Privacy" forecasts that between 2014 and 2020 nearly ... to smart mobile devices by 2.2 billion mobile ... to generate more than $67.9 billion in total ...    "Biometrics is at the center ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
Breaking Biology News(10 mins):Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... This news release is available in German ... are evidently much more specific than previously assumed. More precise tests ... future. This is the result of studies carried out by the ... the Haukeland University Hospital in Bergen. The researchers examined patients with ...
... NEW YORK, NY - December 10, 2013 Researchers ... a virulent new strain of influenza the virus that causes ... disease in humans even after it develops resistance to antiviral medications. ... in the journal Nature Communications . It is ...
... Sirtuin family of protein deacylases has received considerable attention ... diabetes, cancer, and metabolic regulation. In a new study ... Cell Metabolism , Buck Institute researchers have now identified ... mitochondrial sirtuin, SIRT5. Using a novel quantitative proteomic ...
Cached Biology News:Each food fish can cause specific allergies 2Each food fish can cause specific allergies 3Mount Sinai researchers say new strain of bird flu packs a punch even after becoming drug-resistant 2SIRT5 regulation has dramatic effect on mitochondrial metabolism 2SIRT5 regulation has dramatic effect on mitochondrial metabolism 3
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech Corporation introduces the ... line of analytical laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, ... resistant and maintenance-free solution for a broad range of vacuum filtration applications. , ...
(Date:7/31/2015)... , July 31, 2015 China Cord ... China,s leading provider of cord blood ... cell storage services, today announced that the Company has ... U.S. Securities and Exchange Commission. The filed Form 20-F ... March 31, 2015. The Form 20-F can be accessed ...
(Date:7/30/2015)... ATLANTA , July 30, 2015 ... leaders to the 2015 AACC Annual Meeting & ... from July 26–30. The meeting showcased revolutionary ... improves the ability of healthcare providers to diagnose ... get effective medical treatment. As ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on ... current state of the global Propanol market with a focus on the Chinese situation. ... Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang ...
Breaking Biology Technology:Sterlitech Launches New Line of Vacuum Pumps 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3
... SAN FRANCISCO, May 5, 2011 Boston Scientific Corporation ... an analysis of its ALTITUDE ® Clinical Science ... lethal arrhythmias without an increase in mortality due to ... risk associated with these shocks is not attributed to ...
... 2011 AlloSource, a leading developer, processor, ... in surgical procedures around the world, broke ground today ...  The construction project, designed by Intergroup Architects and built ... than half of the existing facility. "From ...
... May 5, 2011 Caliper Life Sciences, Inc. (NASDAQ: ... and services for drug discovery and life sciences research ... Group (COG 2011) meeting on May 17th and 18th. ... drug discovery, and diagnostics to discuss the technologies and ...
Cached Biology Technology:ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 2ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 3ALTITUDE Clinical Data Show ICD Therapy Saves Lives Without Mortality Increase from Device Shock 4AlloSource Starts Construction on New Campus 2AlloSource Starts Construction on New Campus 3Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine 2
Ezrin/Radixin/Moesin Antibody...
Rabbit Anti-conjugated Agmatine Polyclonal Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... ( Abpromise for all tested ... Synthetic peptide based on the propeptide ... amino acid sequence is proprietary) ... SWISS Protein ID: ...
Biology Products: